Recent Analysts’ Ratings Updates for Encompass Health (EHC)

Encompass Health (NYSE: EHC) recently received a number of ratings updates from brokerages and research firms:

• 5/3/2025 – Encompass Health was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating.
• 4/28/2025 – Encompass Health had its price target raised by analysts at Royal Bank of Canada from $110.00 to $125.00. They now have an “outperform” rating on the stock.
• 4/28/2025 – Encompass Health had its price target raised by analysts at UBS Group AG from $117.00 to $130.00. They now have a “buy” rating on the stock.
• 4/28/2025 – Encompass Health had its “buy” rating reaffirmed by analysts at Truist Financial Co.. They now have a $135.00 price target on the stock, up previously from $116.00.
• 4/25/2025 – Encompass Health had its price target raised by analysts at KeyCorp from $120.00 to $122.00. They now have an “overweight” rating on the stock.
• 4/25/2025 – Encompass Health had its price target raised by analysts at Barclays PLC from $118.00 to $129.00. They now have an “overweight” rating on the stock.
• 4/25/2025 – Encompass Health was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.
• 4/16/2025 – Encompass Health was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating.
• 4/3/2025 – Encompass Health was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating.

Encompass Health Trading Down 0.4 %

NYSE:EHC opened at $116.12 on Tuesday. The company has a market cap of $11.69 billion, a P/E ratio of 26.04, a P/E/G ratio of 2.31 and a beta of 0.91. Encompass Health Co. has a 1 year low of $82.74 and a 1 year high of $117.98. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. The stock’s fifty day moving average price is $102.07 and its two-hundred day moving average price is $99.39.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.18. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. The firm had revenue of $1.46 billion for the quarter, compared to analysts’ expectations of $1.43 billion. During the same period in the prior year, the business posted $1.12 earnings per share. The company’s revenue was up 10.6% on a year-over-year basis. As a group, analysts expect that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 0.59%. The ex-dividend date is Tuesday, July 1st. Encompass Health’s dividend payout ratio is currently 14.05%.

Insider Activity

In related news, CAO Andrew L. Price sold 5,042 shares of the business’s stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the transaction, the chief accounting officer now owns 69,164 shares in the company, valued at $6,798,129.56. The trade was a 6.79 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP John Patrick Darby sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the completion of the sale, the executive vice president now directly owns 79,710 shares of the company’s stock, valued at approximately $9,149,910.90. This represents a 11.15 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.00% of the stock is currently owned by corporate insiders.

Institutional Trading of Encompass Health

A number of hedge funds have recently modified their holdings of EHC. MassMutual Private Wealth & Trust FSB boosted its position in shares of Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after purchasing an additional 137 shares in the last quarter. Colonial Trust Co SC purchased a new position in shares of Encompass Health in the 4th quarter worth about $29,000. Transce3nd LLC purchased a new stake in Encompass Health during the 4th quarter valued at about $40,000. CBIZ Investment Advisory Services LLC lifted its stake in shares of Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock worth $42,000 after buying an additional 127 shares in the last quarter. Finally, Tompkins Financial Corp purchased a new position in Encompass Health in the 4th quarter worth approximately $46,000. Institutional investors own 97.25% of the company’s stock.

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.